FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and represents a pharmaceutical agent applicable for post-treatment recurrent hepatocellular carcinoma inhibition and containing peretinoin combined with L-isoleucine, L-leucine and L-valine.
EFFECT: invention provides the effective post-treatment recurrent hepatocellular carcinoma inhibition.
20 cl, 1 ex, 1 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| INHIBITOR OF CONTRACTION AND DEVELOPMENT OF LIVER CANCER TO BE APPLIED IN HEPATITIS C POSITIVE PATIENTS SUFFERING FROM CIRRHOSIS | 2005 |
|
RU2372900C2 |
| ANTIBODY-DRUG CONJUGATE LOADED WITH BINARY TOXINS AND ITS USE | 2021 |
|
RU2795148C2 |
| PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDES | 2010 |
|
RU2553656C2 |
| PREPARATION FOR MAGNETIC RESONANCE IMAGING CONTAINING DEUTERATED NATURAL AMINO ACID WITH BRANCHED SIDE CHAIN, AND DIAGNOSTIC TECHNIQUE USING SAID PREPARATION | 2018 |
|
RU2738850C2 |
| COMBINED THERAPY FOR CANCER TREATMENT | 2013 |
|
RU2699546C2 |
| COMPOSITION FOR TREATMENT OF DIABETES MELLITUS | 2016 |
|
RU2679602C1 |
| COMPOSITIONS AND METHODS FOR INCREASING ENERGY METABOLISM | 2013 |
|
RU2655794C2 |
| NOVEL COMPOSITION CONTAINING AMINO ACIDS WITH BRANCHED SIDE CHAINS | 2020 |
|
RU2817963C2 |
| COMPOSITIONS CONTAINING AMINO ACIDS FOR USE IN TREATMENT OF DISEASES ASSOCIATED WITH MITOCHONDRIAL DISFUNCTIONS | 2018 |
|
RU2778296C2 |
| PEPTIDES WITH ANTI-TUMOUR ACTIVITY | 2024 |
|
RU2840111C1 |
